Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $435.07 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $146.85 | 1 | $0 (2017) |
| Merz Pharmaceuticals, LLC | $67.45 | 2 | $0 (2024) |
| ABBVIE INC. | $52.93 | 3 | $0 (2024) |
| Depomed, Inc. | $29.67 | 2 | $0 (2017) |
| GENZYME CORPORATION | $23.96 | 2 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $19.95 | 1 | $0 (2017) |
| Medtronic USA, Inc. | $18.55 | 1 | $0 (2019) |
| SI-BONE, Inc. | $15.17 | 1 | $0 (2018) |
| Genentech USA, Inc. | $12.90 | 1 | $0 (2017) |
| ARBOR PHARMACEUTICALS, INC. | $12.63 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.01 | 3 | ABBVIE INC. ($36.31) |
| 2023 | $16.62 | 1 | AbbVie Inc. ($16.62) |
| 2021 | $44.75 | 1 | Merz Pharmaceuticals, LLC ($44.75) |
| 2019 | $43.74 | 3 | Medtronic USA, Inc. ($18.55) |
| 2018 | $50.82 | 4 | GENZYME CORPORATION ($23.96) |
| 2017 | $220.13 | 6 | Allergan Inc. ($146.85) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/07/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Musculoskeletal | ||||||
| 03/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/31/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/22/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $44.75 | General |
| Category: Musculoskeletal | ||||||
| 10/22/2019 | Medtronic USA, Inc. | SYNCHROMED (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Drug Infusion Systems | ||||||
| 10/10/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Sleep | ||||||
| 03/22/2019 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $12.56 | General |
| Category: Musculoskeletal | ||||||
| 12/13/2018 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | Cash or cash equivalent | $15.17 | General |
| Category: sacroiliac joint dysfunction | ||||||
| 12/04/2018 | GENZYME CORPORATION | LUMIZYME (Drug), POMPE - DISEASE | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 11/14/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Pain Management | ||||||
| 03/20/2018 | GENZYME CORPORATION | LUMIZYME (Drug), POMPE - DISEASE | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 10/18/2017 | Ipsen Biopharmaceuticals, Inc | Dysport 300 U-1 (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Neurology | ||||||
| 09/14/2017 | Allergan Inc. | BOTOX NEURO REHAB (Drug) | Food and Beverage | In-kind items and services | $146.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2017 | Depomed, Inc. | Nucynta (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Pain | ||||||
| 05/17/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $12.90 | General |
| 03/28/2017 | SANOFI-AVENTIS U.S. LLC | LANTUS (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: DIABETES | ||||||
| 02/23/2017 | Depomed, Inc. | Nucynta (Drug), Gralise | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 435 | 548 | $150,938 | $47,386 |
| 2022 | 13 | 608 | 790 | $225,380 | $71,871 |
| 2021 | 14 | 653 | 892 | $258,305 | $84,693 |
| 2020 | 15 | 618 | 828 | $233,482 | $71,072 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 129 | 192 | $52,224 | $15,464 | 29.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 66 | 88 | $26,576 | $12,189 | 45.9% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 64 | 68 | $41,140 | $9,648 | 23.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 54 | 54 | $24,786 | $9,089 | 36.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $13,870 | $5,019 | 36.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 64 | $10,880 | $4,027 | 37.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 39 | 39 | $9,321 | $3,384 | 36.3% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 27 | 28 | $12,684 | $3,183 | 25.1% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 16 | 16 | $11,760 | $2,734 | 23.3% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2021 | 16 | 16 | $5,968 | $1,394 | 23.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 12 | 12 | $1,968 | $637.14 | 32.4% |
| 76882 | Partial ultrasound of joint or other non-blood vessel structure of arm or leg | Office | 2021 | 12 | 13 | $2,080 | $507.36 | 24.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 13 | 75 | $1,200 | $77.31 | 6.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 101 | 180 | $41,760 | $14,452 | 34.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 128 | 186 | $50,592 | $14,007 | 27.7% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 48 | 49 | $29,645 | $6,916 | 23.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 53 | 61 | $18,422 | $6,616 | 35.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 46 | 46 | $16,790 | $5,901 | 35.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 33 | 33 | $15,147 | $5,251 | 34.7% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2020 | 26 | 26 | $19,110 | $4,653 | 24.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 57 | $9,690 | $3,320 | 34.3% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2020 | 27 | 27 | $12,231 | $2,772 | 22.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 32 | 32 | $7,648 | $2,731 | 35.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 23 | 25 | $2,000 | $1,485 | 74.2% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2020 | 15 | 15 | $5,595 | $1,286 | 23.0% |
About Dr. Paul Brockman, M.D
Dr. Paul Brockman, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902864465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Brockman, M.D has received a total of $435.07 in payments from pharmaceutical and medical device companies, with $59.01 received in 2024. These payments were reported across 18 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($435.07).
As a Medicare-enrolled provider, Brockman has provided services to 2,314 Medicare beneficiaries, totaling 3,058 services with total Medicare billing of $275,022. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Wyomissing, PA
- Active Since 05/03/2006
- Last Updated 03/25/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1902864465
Products in Payments
- BOTOX NEURO REHAB (Drug) $146.85
- Xeomin (Biological) $67.45
- BOTOX (Biological) $52.93
- Nucynta (Drug) $29.67
- LUMIZYME (Drug) $23.96
- Dysport 300 U-1 (Drug) $19.95
- SYNCHROMED (Device) $18.55
- iFuse Implant (Device) $15.17
- Horizant (Drug) $12.63
- Zilretta (Drug) $12.56
- Morphabond ER (Drug) $11.69
- LANTUS (Drug) $10.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Wyomissing
Haiping Mei, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,696
Li-Hong Lu, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,263
Kelley Crozier, Md, MD
Physical Medicine & Rehabilitation — Payments: $730.41
Sanghoon Kim, Md, MD
Physical Medicine & Rehabilitation — Payments: $588.08
Somkiat Hemtasilpa, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $428.76
Mary Elmer
Physical Medicine & Rehabilitation — Payments: $215.26